H. Pylori Fight / H. Pylori Formula (Pylopass DSM 17648)
Digestion / Probiotic postbiotic · Listed at ~€33 (EU) or ~$26 (US) for 60 caps when checked; batch COA link present on page.
Strength
Uses a patented, inactivated L. reuteri strain (DSM 17648) with RCT data showing improved eradication rates as an adjunct to standard therapy and fewer GI adverse effects.
Weakness
Label and web content must avoid disease-treatment claims in the U.S.; COA presentation does not show identity/potency counts for DSM 17648 (cells are inactivated).
Evidence
SuperSmart product page; PubMed RCTs in 2023–2024 show higher eradication vs placebo when used adjunctively.
Evidence-aligned adjunct for those on clinician-guided H. pylori protocols; not a stand-alone treatment.